• 1. An approach for correlating the structural and electrical properties of Zr4+-modified SrBi4Ti4O15/SBT ceramic
  Priyambada Nayak,Tanmaya Badapanda,Anil Kumar Singh,Simanchalo Panigrahi RSC Adv., 2017,7, 16319-16331
• 2. An amphoteric reactivity of a mixed-valent bis(μ-oxo)dimanganese(iii,iv) complex acting as an electrophile and a nucleophile?
  Muniyandi Sankaralingam,So Hyun Jeon,Yong-Min Lee,Mi Sook Seo,Wonwoo Nam Dalton Trans., 2016,45, 376-383
• 3. An integrated cathode and solid electrolyte via in situ polymerization with significantly reduced interface resistance?
  Jialiang Yuan,Ran Dong,Yuan Li,Yang Liu,Zhuo Zheng,Yuxia Liu,Yan Sun,Benhe Zhong,Zhenguo Wu,Xiaodong Guo Chem. Commun., 2021,57, 13004-13007
• 4. An apparatus for testing water by measurement of its electrical conductivity
  Analyst, 1912,37, 538-543
• 5. An all-solid-state asymmetric device based on a polyaniline hydrogel for a high energy flexible supercapacitor?
  Hamid Heydari,Mohammad B. Gholivand New J. Chem., 2017,41, 237-244

Recent Advances in the Study of 7,7,9,9-Tetrafluorobicyclo[3.3.1]nonane-3-carboxylic Acid (CAS: 2580209-50-1)

The compound 7,7,9,9-tetrafluorobicyclo[3.3.1]nonane-3-carboxylic acid (CAS: 2580209-50-1) has recently garnered significant attention in the field of chemical biology and pharmaceutical research. This bicyclic fluorinated carboxylic acid exhibits unique structural and electronic properties, making it a promising candidate for various applications, including drug design, material science, and catalysis. Recent studies have focused on its synthesis, physicochemical properties, and potential biological activities, shedding light on its versatility and utility in medicinal chemistry.

One of the key breakthroughs in the study of this compound is its efficient synthesis via a multi-step fluorination strategy. Researchers have optimized the reaction conditions to achieve high yields and purity, which is critical for its application in pharmaceutical development. The presence of four fluorine atoms in the bicyclic framework enhances its metabolic stability and lipophilicity, properties that are highly desirable in drug candidates. Computational studies have further elucidated the conformational preferences and electronic effects of the fluorinated groups, providing insights into its reactivity and interaction with biological targets.

In the context of medicinal chemistry, 7,7,9,9-tetrafluorobicyclo[3.3.1]nonane-3-carboxylic acid has been explored as a scaffold for the design of novel enzyme inhibitors. Preliminary in vitro studies have demonstrated its ability to modulate the activity of certain proteases and kinases, suggesting potential therapeutic applications in diseases such as cancer and inflammatory disorders. Additionally, its fluorinated structure offers advantages in positron emission tomography (PET) imaging, where it can serve as a radiolabeled probe for diagnostic purposes.

Beyond its biological applications, this compound has also shown promise in material science. Its rigid, fluorinated core imparts exceptional thermal and chemical stability, making it suitable for the development of high-performance polymers and coatings. Recent investigations have highlighted its role in the synthesis of advanced materials with tailored properties, such as low surface energy and high resistance to degradation.

In conclusion, the ongoing research on 7,7,9,9-tetrafluorobicyclo[3.3.1]nonane-3-carboxylic acid (CAS: 2580209-50-1) underscores its multifaceted potential in both pharmaceutical and material science domains. Future studies are expected to further explore its mechanistic details, optimize its synthetic routes, and expand its applications, paving the way for innovative solutions in chemical biology and beyond.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)